Doximity: Priced Like SaaS, Built Like Advertising [Seeking Alpha]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Seeking Alpha
DOCS relies on pharma marketing budgets rather than direct physician monetization, capping revenue growth despite high engagement and AI investment. R&D spend surged 54% YoY to drive engagement, but revenue growth lags at 10%, compressing margins and highlighting a disconnect. Valuation reflects SaaS multiples, but DOCS operates more like an ad business, suggesting 25–45% downside if multiples re-rate to 3–4x sales. Jonathan Kitchen/DigitalVision via Getty Images According to the latest data , over 85% of US doctors are already using Doximity, Inc. ( DOCS ). The platform has over 3+ million registered HCP members. Its free AI tools are used by around 300k
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack [Seeking Alpha]Seeking Alpha
- Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026 [Yahoo! Finance]Yahoo! Finance
- Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026Business Wire
- Doximity (DOCS) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Doximity (DOCS) was given a new $29.00 price target by Truist Financial Corporation.MarketBeat
DOCS
Earnings
- 2/5/26 - Beat
DOCS
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/17/26 - Form 8-K
- 4/14/26 - Form 4
- DOCS's page on the SEC website